Dr Rayyan Zafar

Dr. Rayyan Zafar, PhD MRSB, is a Neuropsychopharmacologist and Wellcome postdoctoral fellow at Imperial College London's Centre for Psychedelic Research. Working with Professor David Nutt, he studies the brain mechanisms of addiction and psychedelic therapy. Zafar is leading the world’s first clinical and brain imaging study on psilocybin therapy for gambling addiction. He is also a senior researcher at Drug Science, a lead research partner at ITER Investments, and an advisor for companies in the psychedelic, cannabis, and wellness industries. Through media appearances and talks, Zafar shares his insights on drugs, mental health, and psychedelics, aiming to foster understanding. He was recently named one of the top 25 emerging leaders in psychedelic science.